<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03571451</url>
  </required_header>
  <id_info>
    <org_study_id>PDTAP study</org_study_id>
    <nct_id>NCT03571451</nct_id>
  </id_info>
  <brief_title>A Multi-center Prospective Cohort Study Based on Peritoneal Dialysis Telemedicine-based Management Platform</brief_title>
  <acronym>PDTAP</acronym>
  <official_title>A Multi-center Prospective Cohort Study Based on Peritoneal Dialysis Telemedicine-based Management Platform</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Peking University First Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>The Second Hospital of Hebei Medical University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Xinqiao Hospital of Chongqing</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Peking University Shenzhen Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hebei Medical University Third Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The First Affiliated Hospital of Zhengzhou University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Cangzhou Central Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Pingdingshan first people's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Beijing Haidian Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The Second Affiliated Hospital of Harbin Medical University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>the Second Affiliated Hospital of Anhui Medical University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Second Hospital of Shanxi Medical University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The First Affiliated Hospital of BaoTou Medical College</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>People's Hospitel of Qinghai Province</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>First Hospital of Jilin University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Beijing miyun district hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The first people's hospital of Xining</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Taiyuan central hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>People's hospital of Langfang</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Beijing Charity Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Handan Central Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>People's hospital of Chuxiong</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Shengjing hospital affiliated to China Medical University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>People's Hospital of Cangzhou</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>People's Hospital of Gansu</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Beijing dongzhimen Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Peking University People's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Peking University First Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Increasing the proportion of patients on peritoneal dialysis (PD) may relieve the financial
      burden caused by the growing number of patients with end-stage renal disease (ESRD). The
      investigators are developing a PD database in China using peritoneal dialysis
      telemedicine-based management platform (PD TAP). The survival rate and technique survival
      rate of PD patients, as well as risk factors associated with survival and technique survival
      will be analyzed through PD TAP.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The growing number of patients with ESRD leads to an increasing medical burden all around the
      world. Patients on PD have a similar long-term survival rate as patients on hemodialysis,
      with a much lower cost of medical resources. Therefore, increasing the percentage of patients
      on PD may relieve the increasing financial burden for the whole society.

      Of note, technique survival and patient survival in PD still need to be improved. Based on
      results from multi-center cohort studies, some prognostic factors have been explored and
      intervened in recent years. However, robust data from large samples on potential predictors
      pertaining to patients' clinical characteristics, and PD practice on clinical outcomes in the
      real world is still limited. This phenomenon calls an action on exploring novel risk factors
      of patient outcome, especially through national-level prospective cohort study.

      The investigators are developing a national-level PD database by registering all patients
      receiving PD on PD TAP. The study is underway in 27 hospitals from 14 provinces located at 7
      geographical regions (northwest, northeast, north, central, southwest, southeast and south)
      in China. National samples of PD units are recruited based on the availability of
      professional PD team who is willing participant and could regularly follow participants. Our
      study aims to enroll adult 7,000 patients with end stage renal disease receiving PD.
      Patients-, treatment- and telemedicine-level variables are collected at baseline and thus at
      3-month intervals. PD practice surveys are collected at baseline. All-cause mortality and
      transfer to hemodialysis will be recorded as primary outcomes. Other clinical outcomes
      including infectious and non-infectious complications would be recorded. The follow-up will
      be continued until the end of the study.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 1, 2016</start_date>
  <completion_date type="Anticipated">December 1, 2025</completion_date>
  <primary_completion_date type="Anticipated">July 1, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>All-cause death</measure>
    <time_frame>10 years</time_frame>
    <description>All-cause death refers to the number of patients who died within the anticipated time frame.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Transfer to hemodialysis</measure>
    <time_frame>10 years</time_frame>
    <description>Transfer to hemodialysis refers to the number of patients who were Transfer to hemodialysis from PD due to any cause within the anticipated time frame.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Peritonitis</measure>
    <time_frame>10 years</time_frame>
    <description>The incidence of peritoneal dialysis related peritonitis during the time frame.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Exit-site/tunnel infection</measure>
    <time_frame>10 years</time_frame>
    <description>The incidence of exit-site/tunnel infection during the time frame.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cardiovascular events</measure>
    <time_frame>10 years</time_frame>
    <description>The incidence of cardiovascular events during the time frame.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Abdominal wall complications</measure>
    <time_frame>10 years</time_frame>
    <description>The incidence of abdominal wall complications occurred during the time frame.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Other non-infectious complications</measure>
    <time_frame>10 years</time_frame>
    <description>The incidence of other non-infectious complications during the time frame</description>
  </secondary_outcome>
  <enrollment type="Anticipated">7000</enrollment>
  <condition>Peritoneal Dialysis</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with end-stage renal disease receiving maintenance peritoneal dialysis
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  End-stage renal disease patients receiving maintenance peritoneal dialysis;

          -  more than 14 years old

        Exclusion Criteria:

          -  receiving temporary PD due to acute kidney injury

          -  loss to follow up without any outcomes recorded.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>14 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jie Dong, MD,Ph.D.</last_name>
    <role>Study Director</role>
    <affiliation>Peking University First Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jie Dong, MD,Ph.D.</last_name>
    <phone>086-010-83572388</phone>
    <email>jie.dong@bjmu.edu.cn</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Yuhui Zhang, MD</last_name>
    <phone>086-010-83572532</phone>
    <email>451076336@qq.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>The second affiliated hospital of Anhui Medical University</name>
      <address>
        <city>Hefei</city>
        <state>Anhui</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Peking University First Hospital</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100034</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jie Dong, MD, Ph.D.</last_name>
      <phone>086-010-83572388</phone>
      <email>jie.dong@bjmu.edu.cn</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>People's Hospital of Gansu Province</name>
      <address>
        <city>Lanzhou</city>
        <state>Gansu</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Peking University Shenzhen Hospital</name>
      <address>
        <city>Shenzhen</city>
        <state>Guangdong</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Cangzhou central hospital</name>
      <address>
        <city>Cangzhou</city>
        <state>Hebei</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nan Zhao, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>People's hospital of Cangzhou</name>
      <address>
        <city>Cangzhou</city>
        <state>Hebei</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Handan Central Hospital</name>
      <address>
        <city>Handan</city>
        <state>Hebei</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>People's hospital of Langfang</name>
      <address>
        <city>Langfang</city>
        <state>Hebei</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>The second hospital of Hebei medical university</name>
      <address>
        <city>Shijiazhuang</city>
        <state>Hebei</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>The third hospital of Hebei Medical University</name>
      <address>
        <city>Shijiazhuang</city>
        <state>Hebei</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>The second affiliated hospital of Harbin Medical University</name>
      <address>
        <city>Harbin</city>
        <state>Heilongjiang</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Pingdingshan People's Hospital No.1</name>
      <address>
        <city>Pingdingshan</city>
        <state>Henan</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xianzhao Zhang, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>First affiliated hospital of Zhengzhou University</name>
      <address>
        <city>Zhengzhou</city>
        <state>Henan</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>The first affiliated hospital of Baotou Medical College</name>
      <address>
        <city>Baotou</city>
        <state>Inner Mongolia</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>The first hospital of Jilin University</name>
      <address>
        <city>Changchun</city>
        <state>Jilin</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Shengjing hospital affiliated to China Medical University</name>
      <address>
        <city>Liaoyang</city>
        <state>Liaoning</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>People's Hospitel of Qinghai Province</name>
      <address>
        <city>Xining</city>
        <state>Qinghai</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>The first people's hospital of Xining</name>
      <address>
        <city>Xining</city>
        <state>Qinghai</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Taiyuan central hospital</name>
      <address>
        <city>Taiyuan</city>
        <state>Shanxi</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>The second hospital of Shanxi Medical University</name>
      <address>
        <city>Taiyuan</city>
        <state>Shanxi</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>The People's Hospital of Chuxiong Yi Autonomous Prefecture</name>
      <address>
        <city>Chuxiong</city>
        <state>Yunnan</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wenxi Zhao, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Beijing Charity Hospital</name>
      <address>
        <city>Beijing</city>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Beijing dongzhimen Hospital</name>
      <address>
        <city>Beijing</city>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Beijing haidian hospital</name>
      <address>
        <city>Beijing</city>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Beijing miyun district hospital</name>
      <address>
        <city>Beijing</city>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Peking University People's Hospital</name>
      <address>
        <city>Beijing</city>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Xinqiao hospital of the Third Military Medical University</name>
      <address>
        <city>Chongqing</city>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>December 2019</verification_date>
  <study_first_submitted>June 20, 2018</study_first_submitted>
  <study_first_submitted_qc>June 22, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">June 27, 2018</study_first_posted>
  <last_update_submitted>December 2, 2019</last_update_submitted>
  <last_update_submitted_qc>December 2, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">December 4, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Peking University First Hospital</investigator_affiliation>
    <investigator_full_name>Dong Jie</investigator_full_name>
    <investigator_title>Director of Peritoneal dialysis center</investigator_title>
  </responsible_party>
  <keyword>peritoneal dialysis</keyword>
  <keyword>survival rate</keyword>
  <keyword>technique survival rate</keyword>
  <keyword>risk factors</keyword>
  <keyword>end stage renal disease</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

